ACADIA PHARMACEUTICALS INC (ACAD)
US0042251084 - Common Stock
| MRQ (2023-9-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 98.20M | 114.80M | 147.40M | 326.00M | 189.70M | |||
| Marketable Securities | 247.70M | 302.00M | 373.30M | 305.90M | 507.70M | |||
| Receivables | 94.50M | 63.10M | 65.30M | 50.30M | 37.90M | |||
| Inventories | 20.80M | 6.60M | 7.90M | 9.70M | 6.30M | |||
| Other Current Assets | 38.00M | 21.40M | 23.90M | 25.70M | 18.60M | |||
| Total Current Assets | 499.20M | 507.90M | 617.80M | 717.60M | 760.30M | |||
| Non-Current Assets | ||||||||
| PPE Net | 55.60M | 61.60M | 66.30M | 56.40M | 12.70M | |||
| Intangibles | 66.90M | N/A | 0.00 | 1.10M | 2.60M | |||
| Other Non-Current Assets | 10.90M | 18.30M | 16.00M | 7.40M | 7.60M | |||
| Total Non-Current Assets | 133.30M | 79.90M | 82.30M | 65.00M | 22.90M | |||
| TOTAL ASSETS | 632.50M | 587.80M | 700.10M | 782.60M | 783.20M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 197.30M | 112.90M | 89.20M | 97.50M | 67.60M | |||
| Accounts Payable | 12.30M | 12.70M | 6.90M | 8.50M | 7.20M | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | |||
| Total Current Liabilities | 209.60M | 125.60M | 96.10M | 106.00M | 74.80M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 60.80M | 61.80M | 63.20M | 49.60M | 9.20M | |||
| Total Non-Current Liabilities | 60.80M | 61.80M | 63.10M | 49.60M | 9.20M | |||
| TOTAL LIABILITIES | 270.40M | 187.40M | 159.20M | 155.60M | 84.00M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -2.48B | -2.37B | -2.15B | -1.99B | -1.70B | |||
| Additional Paid In Capital | 2.84B | 2.77B | 2.69B | 2.61B | 2.40B | |||
| Common Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -300.00K | -1.00M | -200.00K | 0.00 | 300.00K | |||
| Shares Outstanding | 164.00M | 162.10M | 161.00M | 159.60M | 155.30M | |||
| Tangible Book Value per Share | 1.80 | 2.47 | 3.36 | 3.92 | 4.48 | |||
| Total Shareholders' Equity | 362.20M | 400.40M | 540.90M | 627.00M | 699.10M | |||
| TOTAL LIABILITIES AND EQUITY | 632.50M | 587.80M | 700.10M | 782.60M | 783.20M | |||
| Statistics | ||||||||
| Current Ratio | 2.38 | 4.04 | 6.43 | 6.77 | 10.16 | |||
| Return On Assets (ROA) | -23.53% | -36.75% | -23.98% | -35.98% | -30.04% | |||
| Return On Equity (ROE) | -41.08% | -53.95% | -31.04% | -44.91% | -33.66% | |||
All data in USD